FDA NDC Directory · JSON-LD · Markdown

Diflunisal

NDC 70771-1083 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerZydus Lifesciences Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA203547
Dosage form / routeTABLET · ORAL
Active ingredientsDIFLUNISAL (500 mg/1)
Marketing started20170914
Package count7

External sources

Source: openFDA. Public-domain (CC0).